Stefan Claes

ORCID: 0000-0003-0558-401X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Effects of Radiation Exposure
  • Laser Applications in Dentistry and Medicine
  • Nonmelanoma Skin Cancer Studies
  • Oral health in cancer treatment
  • Dermatologic Treatments and Research
  • Chemotherapy-related skin toxicity
  • Photodynamic Therapy Research Studies
  • Skin Protection and Aging
  • Endometrial and Cervical Cancer Treatments
  • Breast Cancer Treatment Studies
  • Cancer survivorship and care
  • Nail Diseases and Treatments
  • Advanced Radiotherapy Techniques
  • Reproductive System and Pregnancy
  • Ovarian cancer diagnosis and treatment
  • Stress Responses and Cortisol
  • Tryptophan and brain disorders
  • Ultrasound and Hyperthermia Applications
  • Advances in Oncology and Radiotherapy
  • Cervical Cancer and HPV Research
  • Head and Neck Cancer Studies
  • Maternal Mental Health During Pregnancy and Postpartum
  • Cancer Immunotherapy and Biomarkers

KU Leuven
2024

Rega Institute for Medical Research
2024

Jessa Hospital
2005-2022

Christie's
2020-2022

Hasselt University
2020-2022

Ziekenhuis Oost-Limburg
2022

Acute radiodermatitis (RD) is a distressing and painful skin reaction that occurs in 95% of the patients undergoing radiotherapy (RT). The aim this study was to evaluate effectiveness photobiomodulation therapy (PBMT) prevention acute RD breast cancer (BC) RT.

10.1002/lsm.22804 article EN Lasers in Surgery and Medicine 2018-02-10

Background and purposeThe purpose of this study was to investigate the effectiveness photobiomodulation therapy (PBMT) for prevention acute radiation dermatitis (ARD) in head neck cancer (HNC) patients.Materials methodsA randomised, placebo-controlled trial (RCT) with 46 HNC patients who underwent radiotherapy (RT) or without concomitant chemotherapy set up (DERMISHEAD trial). Patients were randomised receive PBM placebo treatments from first day RT (2×/week) alongside institutional...

10.1016/j.radonc.2021.03.002 article EN cc-by-nc-nd Radiotherapy and Oncology 2021-03-11

The aim of this study was to investigate the consensus skin care advice given by nurses during radiotherapy. Sixty-seven nurses, identified through nine Belgian radiotherapy departments, responded a questionnaire survey consisting 58 items regarding prevention and management erythema, dry desquamation moist desquamation. Consensus for categorized as small if less than 50% gave same answer, moderate between 75% large when more 75%. Overall, 33% showed consensus, 29% 38% consensus. highest...

10.1111/j.1365-2354.2005.00510.x article EN European Journal of Cancer Care 2005-02-07

Abstract Objectives To evaluate the efficacy of photobiomodulation therapy in breast cancer patients post‐lumpectomy undergoing hypofractionated whole‐breast irradiation (HF‐WBI) for prevention and management acute radiodermatitis (ARD). Materials Methods A randomized, multicentric clinical trial (LABRA trial, NCT03924011) was set up at Limburg Oncology Center, including Jessa Hospital (Hasselt, BE) Ziekenhuis Oost‐Limburg (Genk, BE). total 71 planned to undergo HF‐WBI were randomized one...

10.1002/lsm.23475 article EN Lasers in Surgery and Medicine 2021-09-04

Abstract Objectives The evidence demonstrating the efficacy of photobiomodulation (PBM) therapy for preventing and managing acute radiation dermatitis (ARD) is growing steadily. question that arises from many clinicians is, if PBM safe oncologic patients. This study aimed to evaluate disease‐free survival (DFS), cancer‐free (CFS), overall (OS) breast cancer patients treated with ARD. Methods Clinical data 120 prophylactic ( n = 60, 2x/week, 808−905 nm, 4 J/cm 2 ) or placebo 60) during...

10.1002/lsm.23608 article EN Lasers in Surgery and Medicine 2022-10-02

The objective of this retrospective analysis was to determine the incidence and extent vaginal mucositis (VM) in women with gynaecological cancer undergoing external (chemo)radiation therapy (CRT). A set up collect data on severity VM treated pelvic RT for at Jessa Hospital, Hasselt ZOL, Genk, BE between January 2017 June 2018. At start end their (C)RT, they rated frequency intensity five common symptoms VM. Thirty-three patients met inclusion criteria. non-negligible proportion already...

10.1080/01443615.2022.2035329 article EN Journal of Obstetrics and Gynaecology 2022-02-16

<h3>Background</h3> High-grade serous ovarian cancer has a recurrence and mortality rate of approximately 80%. The impact disease on the immune system remains unclear. Understanding this could potentially enhance our future therapeutic strategies. <h3>Materials Methods</h3> We monitored 27 recurrent patients treated with second-line chemotherapy (carboplatin-gemcitabine) and/or PARP(Poly(ADP-ribose)polymerase)-inhibition (PARPi) (OV-IMM-2014, S56311, University Hospitals Leuven). PARPi was...

10.1136/jitc-2024-itoc10.27 article EN cc-by-nc Poster presentations 2024-03-01

Abstract Background The ADNEX model (Assessment of Different NEoplasias in the adnexa) is best performing to predict risk malignancy (binary) and type (multiclass) ovarian tumors. immune system plays a role onset progression cancer. Preliminary research has suggested that immune-related biomarkers can help discrimination We aimed assess which proteins have most additional diagnostic value addition ADNEX’ clinical ultrasound predictors. Materials methods In this exploratory study, 1086...

10.1101/2024.03.14.24304282 preprint EN cc-by-nd medRxiv (Cold Spring Harbor Laboratory) 2024-03-15

Acute radiation dermatitis (ARD) is a frequent adverse effect in patients with cancer undergoing radiotherapy (RT). The aim of this case series to evaluate the novel skin barrier protectant ARD.The was used four different types RT at two clinical sites. All received standard institutional skincare alongside protectant. reactions were evaluated by an nurse using modified version Radiation Therapy Oncology Group criteria.At final session, three developed erythema or without dry desquamation....

10.1097/01.asw.0000826824.10120.fe article EN Advances in Skin & Wound Care 2022-05-12

To evaluate the use of a novel skin barrier protectant in patient treated with radiotherapy for vulvar cancer.This case report was conducted department two women undergoing carcinoma. A evaluated one patient; other underwent institutional standard care protocol. Skin reactions and pain were using Radiotherapy Oncology Group Criteria.The who showed accelerated healing toward end radiotherapy, this accompanied decrease (maximum score 6/10). In comparison, protocol had an extended process,...

10.1097/01.asw.0000722768.95461.82 article EN Advances in Skin & Wound Care 2020-12-14

ConclusionHigh pre-treatment CAC based on planning CT scans is associated with ACE in BC patients treated postoperative RT, even after correction for confounding factors such as MHD.

10.1016/s0167-8140(18)30402-x article EN cc-by-nc-nd Radiotherapy and Oncology 2018-04-01
Coming Soon ...